Betahistine
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Betahistine
Description:
Betahistine is an orally active histamine H1 receptor agonist and a H3 receptor antagonist[1]. Betahistine is used for the study of rheumatoid arthritis (RA) [3].UNSPSC:
12352005Hazard Statement:
H315, H319, H335Target:
Histamine ReceptorType:
Reference compoundRelated Pathways:
GPCR/G Protein; Immunology/Inflammation; Neuronal SignalingApplications:
COVID-19-immunoregulationField of Research:
Cancer; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/betahistine.htmlConcentration:
10mMPurity:
99.84Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
CNCCC1=NC=CC=C1Molecular Formula:
C8H12N2Molecular Weight:
136.19Precautions:
H315, H319, H335References & Citations:
[1]Poyurovsky M, et al. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Int Clin Psychopharmacol. 2005 Mar;20 (2) :101-3.|[2]Gbahou F, et al. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.J Pharmacol Exp Ther. 2010 Sep 1;334 (3) :945-54.|[3]Tang KT, et al. Betahistine attenuates murine collagen-induced arthritis by suppressing both inflammatory and Th17 cell responses.Int Immunopharmacol. 2016 Oct;39:236-245.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
LaunchedIsoform:
H1 Receptor; H3 ReceptorCitation 01:
Pharm Res. 2025 Aug;42 (8) :1315-1329.|Brain Sci. 2025 Aug 25.CAS Number:
[5638-76-6]
